CardioTech to research new polyurethanes:
This article was originally published in Clinica
CardioTech International, of Woburn, Minneapolis, has received a research grant of nearly $100,000 from the National Heart, Lung and Blood Institute to develop new infection resistant polyurethanes. Covering a period of six months, this Phase I grant aims to develop a synthetic polyurethane material using quinolones antibiotics. The infection-resistant biomaterials can then be applied to a range of implanted devices such as indwelling catheters, vascular grafts and stents.
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.